Matches in SemOpenAlex for { <https://semopenalex.org/work/W937036191> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W937036191 endingPage "7" @default.
- W937036191 startingPage "1011" @default.
- W937036191 abstract "To assess the clinical features of the dopamine (DA) metabolism in chronic renal failure patients (CRF), measurements were made of the plasma DA, norepinephrine (NE), epinephrine (EN) and their urinary metabolites in 6 healthy controls and 13 CRF patients before and after administration of oral DA (KW-3160, Kyowa Hakko Kogyo Co., Ltd.). The data obtained, including that for impaired DA metabolites in the patients with chronic renal failure, can be summarized as follows: I) Synthesis: In the plasma, the DA, NE and EN levels were not significantly different in the CRF patients as compared to those in normal controls, but the excretions of urinary free DA, NE and EN were markedly lower, and the free and conjugated DA, NE and EN levels were significantly decreased in the CRF patients after DA administration. These findings indicate that the plasma dopamine beta-hydroxylase activity is inhibited in CRF patients. II) Degradation: Increased levels of urinary free and conjugated 3,4-dihydroxy phenylacetic acid (DOPAC) and decreased levels of urinary conjugated homovanillic acid (HVA) were observed, indicating that the monoamine oxidase (MAO) activity in the plasma is possibly augmented, and the catecholamine O-methyl transferase (COMT) activity inhibited, in uremic patients. III) Excretion: The urinary excretions of free DOPAC, HVA, NE and vanillylmandelic acid (VMA) and of conjugated DA and DOPAC were significantly correlated with the creatinine clearance. These data suggest that the excretion of urinary DA and part of its metabolites may be regulated by the renal function." @default.
- W937036191 created "2016-06-24" @default.
- W937036191 creator A5008931622 @default.
- W937036191 creator A5027652792 @default.
- W937036191 creator A5028354716 @default.
- W937036191 creator A5032449603 @default.
- W937036191 creator A5047058883 @default.
- W937036191 creator A5090643926 @default.
- W937036191 date "1992-09-01" @default.
- W937036191 modified "2023-09-23" @default.
- W937036191 title "Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure." @default.
- W937036191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1479729" @default.
- W937036191 hasPublicationYear "1992" @default.
- W937036191 type Work @default.
- W937036191 sameAs 937036191 @default.
- W937036191 citedByCount "1" @default.
- W937036191 crossrefType "journal-article" @default.
- W937036191 hasAuthorship W937036191A5008931622 @default.
- W937036191 hasAuthorship W937036191A5027652792 @default.
- W937036191 hasAuthorship W937036191A5028354716 @default.
- W937036191 hasAuthorship W937036191A5032449603 @default.
- W937036191 hasAuthorship W937036191A5047058883 @default.
- W937036191 hasAuthorship W937036191A5090643926 @default.
- W937036191 hasConcept C126322002 @default.
- W937036191 hasConcept C134018914 @default.
- W937036191 hasConcept C170493617 @default.
- W937036191 hasConcept C181199279 @default.
- W937036191 hasConcept C185592680 @default.
- W937036191 hasConcept C2775841634 @default.
- W937036191 hasConcept C2775864247 @default.
- W937036191 hasConcept C2775894120 @default.
- W937036191 hasConcept C2776024655 @default.
- W937036191 hasConcept C2779089960 @default.
- W937036191 hasConcept C513476851 @default.
- W937036191 hasConcept C55493867 @default.
- W937036191 hasConcept C71924100 @default.
- W937036191 hasConcept C77411442 @default.
- W937036191 hasConceptScore W937036191C126322002 @default.
- W937036191 hasConceptScore W937036191C134018914 @default.
- W937036191 hasConceptScore W937036191C170493617 @default.
- W937036191 hasConceptScore W937036191C181199279 @default.
- W937036191 hasConceptScore W937036191C185592680 @default.
- W937036191 hasConceptScore W937036191C2775841634 @default.
- W937036191 hasConceptScore W937036191C2775864247 @default.
- W937036191 hasConceptScore W937036191C2775894120 @default.
- W937036191 hasConceptScore W937036191C2776024655 @default.
- W937036191 hasConceptScore W937036191C2779089960 @default.
- W937036191 hasConceptScore W937036191C513476851 @default.
- W937036191 hasConceptScore W937036191C55493867 @default.
- W937036191 hasConceptScore W937036191C71924100 @default.
- W937036191 hasConceptScore W937036191C77411442 @default.
- W937036191 hasIssue "9" @default.
- W937036191 hasLocation W9370361911 @default.
- W937036191 hasOpenAccess W937036191 @default.
- W937036191 hasPrimaryLocation W9370361911 @default.
- W937036191 hasRelatedWork W1966437072 @default.
- W937036191 hasRelatedWork W1979976706 @default.
- W937036191 hasRelatedWork W1993439566 @default.
- W937036191 hasRelatedWork W1993661560 @default.
- W937036191 hasRelatedWork W2035465482 @default.
- W937036191 hasRelatedWork W2070550862 @default.
- W937036191 hasRelatedWork W2085118254 @default.
- W937036191 hasRelatedWork W2089103608 @default.
- W937036191 hasRelatedWork W2147637614 @default.
- W937036191 hasRelatedWork W2401279029 @default.
- W937036191 hasVolume "34" @default.
- W937036191 isParatext "false" @default.
- W937036191 isRetracted "false" @default.
- W937036191 magId "937036191" @default.
- W937036191 workType "article" @default.